top of page

Current bladder therapies is causing harm to millions of people daily

Writer's picture: Gabriel KornGabriel Korn

Practitioners and investors please take note.

Drugs taken orally to treat common bladder conditions, notably antibiotics and anticholinergics, are causing serious harm to millions of people daily by contributing to the rise in anti-microbial resistance, exposing our helpful gut microbiome to compounds without our knowledge of the risks that they pose to it (and therefore our patients) and from systemic side effects of anticholinergics used to treat urinary urgency. Research has concluded that oral anticholinergics even predispose to dementia. Good drugs are being delivered badly. Clinical practice for treating bladder diseases and disorders must change.

UroPharma has designed, developed, and patented the dtb-Instilla, a urine drainage and direct-to-bladder drug-delivery device that will enable a beneficial disruption of a wide-range of clinical practices by enabling the broad development under licence of intravesical (direct-to-bladder) therapeutics.

We’ll be very interested in your feedback and questions

· See the Market Opportunity https://www.uropharma.com/market-opportunity

· See professionals’ testimonials https://www.uropharma.com/testimonials


Investors: contact us at info@uropharma.com

12 views0 comments

Recent Posts

See All

Aiming at the right urological targets

Last week, Professor of urology, Chris Chapple had a review published in  Continence , titled “The sensory system is a target for...

Anachronistic Bladder Treatments

During much of my medical career, my understanding of the human bladder was that it was a reservoir for the body’s metabolic waste and...

Drugs and dementia

Colleagues While I applaud last week’s publication of the Lancet Commission report on Dementia 2024 that provided updated information on...

Comments


Contact Us

Tel: +44 (0) 1603 626 960

​

Email: info@uropharma.com

©2017-2021 UroPharma, Inc. All Rights Reserved

3.png
2.png

Social Media

  • LinkedIn Social Icon

Linkedin.com/company/uropharma

  • Twitter

Twitter.com/UroPharma

  • Facebook

Facebook.com/bladdercontrol

4_edited_edited.jpg
image.png
bottom of page